This advantage is due to a specific requisite genetic change in the etiology of the vast majority of Rb tumors: the loss of functioning retinoblastoma protein (pRb) often due to mutation or epigenetic silencing of its coding gene, RB1[16]. The gene discussed is RB1; the disease is retinoblastoma.